FDA Inspection 1149904 — Apitoria Pharma Private Limited

Apitoria Pharma Private Limited — FEI 3004021253

The FDA completed an inspection of Apitoria Pharma Private Limited on August 12, 2021 in Sangareddy. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
August 12, 2021
Fiscal Year
2021
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Sangareddy (India)